GRCE is Grace Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.14. Market cap: $45M. Capital Quality Rank: 23/100 — Capital destroyer.
Stock snapshot
| Price | $2.14 |
| Market cap | $45M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 23 / 100 · Capital destroyer |
| ROIC (TTM) | -18.6% |
| Shareholder buyback yield | -26.79% |
| Altman Z-score zone | Grey |
About GRCE
Grace Therapeutics Inc is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Its development pipeline consists of the following product candidates: GTx-104, a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage (aSAH); GTx-102, targeted for the treatment of ataxia-telangiectasia (A-T) in a pediatric population; and GTx-101, a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia (PHN), which can be persistent and often causes debilitating pain following infection by the shingles virus. The company has one reportable operating segment: the development and commercialization of pharmaceutical applications of its patents and licensed rights.
Related non-dividend companies
Other non-dividend stocks investors research alongside GRCE. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is GRCE's current stock price?
GRCE (Grace Therapeutics, Inc.) is currently trading at $2.14.
Does GRCE pay a dividend?
GRCE (Grace Therapeutics, Inc.) does not currently pay a regular dividend.
What is GRCE's Capital Quality Rank?
GRCE has a Capital Quality Rank of 23/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track GRCE in DiviDrip
Add GRCE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search GRCE and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.